« Back to Medicines list

Distaclor LA Tablets 375mg

  • Name:

    Distaclor LA Tablets 375mg

  • Company:
    info
  • Active Ingredients:

    Cefaclor monohydrate

  • Legal Category:

    Product subject to medical prescription which may be renewed (B)

Summary of Product Characteristics last updated on medicines.ie: 12/3/2018
print

Print ViewKeyword Search SmPC

Flynn Pharma Ltd

Flynn Pharma Ltd

Company Products

Medicine NameActive Ingredients
Medicine Name Cefuroxime 1.5 Powder for Injection Active Ingredients Cefuroxime Sodium
Medicine Name Cefuroxime 750mg Powder for Injection Active Ingredients Cefuroxime Sodium
Medicine Name Circadin 2mg prolonged-release tablets Active Ingredients melatonin
Medicine Name Distaclor 125mg/5ml Granules for Oral Suspension Active Ingredients Cefaclor monohydrate
Medicine Name Distaclor 250mg Granules for Oral Suspension Active Ingredients Cefaclor monohydrate
Medicine Name Distaclor LA Forte 500mg Tablet Active Ingredients Cefaclor monohydrate
Medicine Name Distaclor LA Tablets 375mg Active Ingredients Cefaclor monohydrate
Medicine Name Distaclor Suspension Active Ingredients Cefaclor
Medicine Name Keflex 125mg/5ml Powder for Oral Suspension Active Ingredients Cefalexin
Medicine Name Keflex 250mg Hard Capsules Active Ingredients Cefalexin monohydrate
Medicine Name Keflex 250mg Powder for Oral Suspension Active Ingredients Cefalexin
Medicine Name Keflex 500mg Film Coated Tablets Active Ingredients Cefalexin monohydrate
Medicine Name Medikinet MR modified-release capsules, hard Active Ingredients Methylphenidate Hydrochloride
Medicine Name Medikinet Tablets Active Ingredients Methylphenidate Hydrochloride
Medicine Name Vancocin 1g Powder for Oral Solution Active Ingredients Vancomycin Hydrochloride
Medicine Name Vancocin Matrigel 125mg Hard Capsules Active Ingredients Vancomycin Hydrochloride
Medicine Name Vancomycin 500mg Powder for oral solution Active Ingredients Vancomycin Hydrochloride
1 - 0 of 17 items.Total: Infinity pages

When a pharmaceutical company changes any document, a new version is published on medicines.ie. For each version, we show the dates it was published on medicines.ie and the reasons for change.

Updated on 12 March 2018 PIL

Reasons for updating

  • Change to section 10 - Date of revision of the text

Free text change information supplied by the pharmaceutical company

Update date of revision as per request from HPRA

Updated on 12 March 2018 SmPC

Reasons for updating

  • New SmPC for new product

Legal category: Product subject to medical prescription which may be renewed (B)

Updated on 12 March 2018 SmPC

Reasons for updating

  • Change to section 10 - Date of revision of the text

Legal category: Product subject to medical prescription which may be renewed (B)

Free text change information supplied by the pharmaceutical company

Update date of revision as per request from HPRA

Updated on 28 February 2018 PIL

Reasons for updating

  • Change to section 7 - Marketing authorisation holder

Free text change information supplied by the pharmaceutical company

Update MA Holder address

Updated on 28 February 2018 SmPC

Reasons for updating

  • Change to section 7 - Marketing authorisation holder

Legal category: Product subject to medical prescription which may be renewed (B)

Free text change information supplied by the pharmaceutical company

Update MA Holder address

Updated on 16 August 2016 PIL

Reasons for updating

  • Change to Section 4.8 – Undesirable effects - how to report a side effect

Free text change information supplied by the pharmaceutical company

Update Annex V information encouraging reporting of adverse events. Several additional minor changes to the product information to align with the QRD template.

Updated on 16 August 2016 SmPC

Reasons for updating

  • Change to Section 4.8 – Undesirable effects - how to report a side effect

Legal category: Product subject to medical prescription which may be renewed (B)

Free text change information supplied by the pharmaceutical company

Update Annex V information encouraging reporting of adverse events. Several additional minor changes to the product information to align with the QRD template.

Updated on 13 July 2012 PIL

Reasons for updating

  • Change to section 1 - Name of medicinal product
  • Change to section 2 - Qualitative and quantitative composition
  • Change to section 6.1 - List of excipients
  • Change to section 9 - Date of renewal of authorisation
  • Change to section 10 - Date of revision of the text

Free text change information supplied by the pharmaceutical company

In section 1- added "prolonged release tablets"
In section 2- changed "for a full list of excipients, see section 6.1"
In section 6.1- Added "Tablet core" and " Tablet coating"
In section 9- Changed date of renewal " 16th June 2008"
In section 10- Changed date of revision "August 2009"

Updated on 13 July 2012 SmPC

Reasons for updating

  • Change to section 1 - Name of medicinal product
  • Change to section 2 - Qualitative and quantitative composition
  • Change to section 6.1 - List of excipients
  • Change to section 9 - Date of renewal of authorisation
  • Change to section 10 - Date of revision of the text

Legal category: Product subject to medical prescription which may be renewed (B)

Free text change information supplied by the pharmaceutical company

In section 1- added "prolonged release tablets"
In section 2- changed "for a full list of excipients, see section 6.1"
In section 6.1- Added "Tablet core" and " Tablet coating"
In section 9- Changed date of renewal " 16th June 2008"
In section 10- Changed date of revision "August 2009"

Updated on 14 March 2007 PIL

Reasons for updating

  • New SPC for medicines.ie

Updated on 14 March 2007 SmPC

Reasons for updating

  • New SPC for medicines.ie

Legal category: Product subject to medical prescription which may be renewed (B)